<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pediatric Cancer Legislation Tracker | Give Kids a Chance Act & More ‚Äî The 4% Project</title>
    <meta name="description" content="Track key pediatric cancer legislation including the Mikaela Naylon Give Kids a Chance Act (signed February 3, 2026), the Fairness to Kids with Cancer Act, and the RACE for Children Act.">
    <meta name="keywords" content="Mikaela Naylon Give Kids a Chance Act, H.R. 1262, pediatric cancer legislation, Fairness to Kids with Cancer Act, RACE for Children Act, childhood cancer law 2026">
    <meta name="robots" content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1">
    <link rel="canonical" href="https://the4percentproject.org/legislation.html">
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://the4percentproject.org/legislation.html">
    <meta property="og:title" content="Mikaela Naylon Give Kids a Chance Act Signed Into Law ‚Äî February 3, 2026">
    <meta property="og:description" content="After years of near-misses, the landmark pediatric cancer bill became law. Track it and the next battles.">
    <meta property="og:image" content="https://images.unsplash.com/photo-1631815588090-d4bfec5b1ccf?w=1200&h=630&fit=crop">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="Mikaela Naylon Give Kids a Chance Act ‚Äî Signed Into Law">
    <meta name="twitter:image" content="https://images.unsplash.com/photo-1631815588090-d4bfec5b1ccf?w=1200&h=630&fit=crop">
    <script type="application/ld+json">{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://the4percentproject.org/"},{"@type":"ListItem","position":2,"name":"Legislation","item":"https://the4percentproject.org/legislation.html"}]}</script>
    <script type="application/ld+json">{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Was the Mikaela Naylon Give Kids a Chance Act signed into law?","acceptedAnswer":{"@type":"Answer","text":"Yes. The Mikaela Naylon Give Kids a Chance Act (H.R. 1262) was signed into law on February 3, 2026, as part of the FY2026 Consolidated Appropriations Act. It reauthorizes the FDA Rare Pediatric Disease Priority Review Voucher program through 2029."}},{"@type":"Question","name":"Who is Mikaela Naylon?","acceptedAnswer":{"@type":"Answer","text":"Mikaela Naylon was a 16-year-old from Colorado diagnosed with osteosarcoma who advocated for the bill until her death on October 29, 2025. Congress dedicated the signed law in her name."}},{"@type":"Question","name":"What is the Fairness to Kids with Cancer Act?","acceptedAnswer":{"@type":"Answer","text":"The Fairness to Kids with Cancer Act (H.R. 5405) would mandate that NCI funding for childhood cancer research be proportional to the pediatric share of the U.S. population, increasing it from 4% toward approximately 22%."}}]}</script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Libre+Baskerville:wght@400;700&family=Work+Sans:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="/4percent/css/styles.css">
</head>
<body>
<div id="site-header" class="include-placeholder"></div>
<main>
    <section class="page-hero">
        <div class="container">
            <h1>Pediatric Cancer Legislation Tracker</h1>
            <p>Laws won, battles ongoing, and the people behind both sides of the fight.</p>
        </div>
    </section>

    <section>
        <div class="container">

            <!-- Mikaela Spotlight -->
            <div class="mikaela-spotlight">
                <div class="signed-badge">‚úÖ SIGNED INTO LAW ‚Äî February 3, 2026</div>
                <h3>Mikaela Naylon Give Kids a Chance Act</h3>
                <div class="stat-row">
                    <div class="stat-item"><div class="num">313</div><div class="lbl">House co-sponsors</div></div>
                    <div class="stat-item"><div class="num">60+</div><div class="lbl">PRVs awarded since 2012</div></div>
                    <div class="stat-item"><div class="num">2029</div><div class="lbl">PRV program extended through</div></div>
                </div>
                <p>Named for Mikaela Naylon (16, Colorado), who was diagnosed with osteosarcoma in 2020, relapsed four times, underwent a below-knee amputation, and spent her final weeks meeting with lawmakers in Washington and continuing by Zoom as her health declined. She died October 29, 2025. Congress passed the act in her name weeks later.</p>
                <p><strong>Key provisions:</strong> Reauthorizes the FDA Rare Pediatric Disease Priority Review Voucher (PRV) program through 2029 ¬∑ Authorizes FDA to require pediatric trials of drug combinations ¬∑ Extends NIH pediatric research funding through FY2027 ¬∑ Strengthens FDA oversight of required post-market pediatric studies.</p>
                <p style="font-size:0.9rem;opacity:0.75;margin-bottom:1.5rem;"><strong>Legislative history:</strong> Passed House unanimously Dec 1, 2025 ¬∑ Blocked by Sen. Rand Paul at 11:50 PM, Dec 20, 2024 ¬∑ Blocked again by Sen. Bernie Sanders, Dec 2025 ¬∑ Included in FY2026 Consolidated Appropriations Act ¬∑ Signed Feb 3, 2026.</p>
                <a href="https://www.congress.gov/bill/119th-congress/house-bill/1262" target="_blank" class="btn btn-law btn-sm">View H.R. 1262 on Congress.gov ‚Üó</a>
            </div>

            <!-- Active Bills -->
            <h2 style="font-size:1.8rem;color:var(--accent);margin-bottom:2rem;">Bills Still in the Fight</h2>

            <div class="bill-card active">
                <div class="bill-meta">
                    <span class="tag tag-active">Active ‚Äî In Committee</span>
                    <span class="bill-number">H.R. 5405</span>
                </div>
                <h3><a href="https://www.congress.gov/bill/118th-congress/house-bill/5405" target="_blank">Fairness to Kids with Cancer Act</a></h3>
                <p>Would mandate that NCI funding for childhood cancer research be <strong>proportional to the pediatric share of the U.S. population</strong> ‚Äî increasing pediatric research funding from 4% to approximately 22% over time. This single bill would be the most transformative shift in pediatric cancer research funding in history.</p>
                <p>The act has strong bipartisan support and a growing list of co-sponsors, but faces resistance from budget committees and requires additional pressure to advance to a floor vote.</p>
                <a href="https://www.congress.gov/bill/118th-congress/house-bill/5405" target="_blank" class="btn btn-bill btn-sm">View on Congress.gov ‚Üó</a>
            </div>

            <div class="bill-card active">
                <div class="bill-meta">
                    <span class="tag tag-pending">Monitoring</span>
                    <span class="bill-number">H.R. 1231</span>
                </div>
                <h3><a href="https://www.congress.gov/bill/115th-congress/house-bill/1231" target="_blank">RACE for Children Act</a></h3>
                <p>Signed into law in 2017, the Research to Accelerate Cures and Equity (RACE) for Children Act requires pharmaceutical companies to evaluate their molecularly targeted cancer drugs in pediatric populations when the drug's target is relevant to childhood cancers.</p>
                <p>A <a href="https://www.gao.gov/products/gao-23-105947" target="_blank">2023 GAO progress report</a> found the law is beginning to yield results ‚Äî but implementation and enforcement remain areas of active focus. Expansion of the RACE Act's scope is being discussed in the current Congress.</p>
                <a href="https://www.congress.gov/bill/115th-congress/house-bill/1231" target="_blank" class="btn btn-bill btn-sm">View on Congress.gov ‚Üó</a>
                <a href="https://www.gao.gov/products/gao-23-105947" target="_blank" class="btn btn-outline btn-sm">GAO Progress Report ‚Üó</a>
            </div>

            <!-- Champions & Blockers -->
            <div class="two-col" style="margin-top:4rem;">
                <div class="champion-card">
                    <h3>üèÜ Legislative Champions</h3>
                    <div class="rep-item"><span class="rep-star">‚òÖ</span><div><strong>Rep. Michael McCaul (R-TX)</strong> ‚Äî Lead House sponsor, Give Kids a Chance Act</div></div>
                    <div class="rep-item"><span class="rep-star">‚òÖ</span><div><strong>Sen. Markwayne Mullin (R-OK)</strong> ‚Äî Senate champion, Give Kids a Chance Act</div></div>
                    <div class="rep-item"><span class="rep-star">‚òÖ</span><div><strong>Sen. Michael Bennet (D-CO)</strong> ‚Äî Cross-aisle Senate co-sponsor</div></div>
                    <div class="rep-item"><span class="rep-star">‚òÖ</span><div><strong>Rep. Doris Matsui (D-CA)</strong> ‚Äî Fairness to Kids with Cancer Act</div></div>
                    <div class="rep-item"><span class="rep-star">‚òÖ</span><div><strong>Rep. Debbie Dingell (D-MI)</strong> ‚Äî Sustained pediatric cancer advocacy</div></div>
                </div>
                <div class="champion-card blocker-card">
                    <h3>üö´ Who Has Blocked Progress</h3>
                    <div class="rep-item"><span class="rep-x">‚úó</span><div><strong>Sen. Rand Paul (R-KY)</strong> ‚Äî Blocked Give Kids a Chance Act at 11:50 PM, December 20, 2024 via unanimous consent objection</div></div>
                    <div class="rep-item"><span class="rep-x">‚úó</span><div><strong>Sen. Bernie Sanders (D-VT)</strong> ‚Äî Blocked the bill again in December 2025, citing unrelated pharmaceutical pricing disputes</div></div>
                    <div class="rep-item"><span class="rep-x">‚úó</span><div><strong>Pharmaceutical lobbying</strong> ‚Äî Industry opposition to PRV program reforms and mandatory pediatric trial requirements</div></div>
                    <div class="rep-item"><span class="rep-x">‚úó</span><div><strong>Budget committee resistance</strong> ‚Äî Fairness to Kids with Cancer Act stalled over appropriations scoring concerns</div></div>
                </div>
            </div>
        </div>
    </section>
</main>
<div id="site-footer" class="include-placeholder"></div>
<script src="/4percent/js/includes.js"></script>
</body>
</html>